"The Endocrine Center - Houston, TX At The Endocrine Center, we are a group of board-certified specialists in endocrinology and metabolism. We provide in-depth specialty care, and have a wide range of resources available for our patients. We accept a wide range of insurance plans, and can usually accommodate new patient appointments within 2 weeks. We have 3 locations in the Houston area: Main Campus, Greater Heights, Methodist West. We can usually accommodate new patient appointments within 2 weeks. Call on our board-certified specialists to help answer your questions regarding treatment and care: 713-468-2122."

During the past decade, Endocrine Ips, Pllc conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Endocrine Ips, Pllc" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Akebia Therapeutics" with 1 trials sponsored, "Anji Pharma" with 1 trials sponsored, "Mylan Inc." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Endocrine Ips, Pllc" #1 collaborator was "Cyclerion Therapeutics" with 1 trials as a collaborator and "Mylan GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Endocrine Ips, Pllc" are "Type 2 Diabetes" (3 trials), "Obesity" (2 trials), "Overweight" (2 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Endocrine Ips, Pllc" in a lesser frequency.

Most popular intervention types in "Endocrine Ips, Pllc" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "LY3437943" (2 trials), "Dulaglutide" (1 trials), "FlexPen NovoLog®" (1 trials) and "IW-1973" (1 trials). Other intervention names were less common.

The vast majority of trials in "Endocrine Ips, Pllc" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Endocrine Ips, Pllc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Endocrine Ips, Pllc, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Endocrine Ips, Pllc, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".